Results 181 to 190 of about 1,234,411 (332)

Complete amino acid sequence of pooled papain-solubilized HLA-A, -B, and -C antigens: relatedness to immunoglobulins and internal homologies.

, 1980
L Trägårdh, Lars Rask, Klas G. Wiman, Jan Fohlman, P A Peterson   +4 more
openalex   +1 more source

A promising frontier of circulating messenger RNA in liquid biopsy: From mechanisms to clinical applications

International Journal of Cancer, EarlyView.
Abstract Liquid biopsy can revolutionize cancer patient management as repeated sampling allows real‐time monitoring of disease progression and response to treatment. The circulating transcriptome represents a rich source of potential cancer biomarkers, including coding and non‐coding RNAs.
Mengqian Li, Yijin Yu, Guangyue Liu, Shunhong Zhang, Chenchen Luo, Saidi Hu, Siran Wan, Linyong Zhao   +7 more
wiley   +1 more source

Donor-specific antibodies against HLA-C, HLA-DP and HLA-DQ and their implications in kidney transplantation. [PDF]

World J Transplant
Khalil MAM, Sadagah NM, Hediki I, Tan J, Al-Qurashi SH.   +4 more
europepmc   +1 more source

Isolation of a cDNA clone for the human HLA-DR antigen alpha chain by using a synthetic oligonucleotide as a hybridization probe. [PDF]

, 1982
D Stetler, Hasi R. Das, Jack H. Nunberg, Randall K. Saiki, R Sheng-Dong, Kary B. Mullis, S M Weissman, M Kellis   +7 more
openalex   +1 more source

Generation and functional analysis of melanoma antigen‐specific CD8+ T cells derived from S/MAR vector‐transfected human induced pluripotent stem cells

International Journal of Cancer, EarlyView.
What's New? Adoptive cell therapy (ACT) with tumor antigen‐specific CD8+ T cells has shown success in clinical trials treating patients with advanced or metastatic melanoma. Here, the authors established protocols for generating CD8+ T cells from human induced pluripotent stem cells (hiPSCs) expressing a melanoma‐specific T cell receptor (TCR) or ...
Juliane Poelchen, Sandra Pardo, Daniel Novak, Qian Sun, Tamara Steinfass, Marlene Vierthaler, Özge Cicek Sener, Karol Granados Blanco, Yiman Wang, Jan Peter Nicolay, Pierre Guermonprez, Richard Harbottle, Viktor Umansky, Jochen Utikal   +13 more
wiley   +1 more source

Belimumab to Aid Pre-Transplant Immunological Risk-Stratification by Uncovering Broader HLA-Specific Memory B-Cell Profiles. [PDF]

HLA
van den Broek DAJ, Karahan GE, Meziyerh S, de Vaal Y, Bakker KH, Haasnoot GW, Rotmans JI, Teng YKO, van Kooten C, Heidt S, Roelen DL, de Vries APJ.   +11 more
europepmc   +1 more source

Twenty‐year survival outcomes after multipeptide vaccination for resected high‐risk melanoma: A post‐hoc analysis of a randomized clinical trial

International Journal of Cancer, EarlyView.
What's New? While melanoma vaccines have shown therapeutic promise, predicting their clinical benefits is challenged by factors such as delayed response to immunotherapy and scarcity of biomarkers. Here, the authors examined the long‐term efficacy of vaccination with either 4 or 12 class I MHC‐restricted peptides in high‐risk melanoma.
Emily K. Ninmer, Hong Zhu, Kimberly A. Chianese‐Bullock, Craig L. Slingluff Jr.   +3 more
wiley   +1 more source

Computation strategies and clinical applications in neoantigen discovery towards precision cancer immunotherapy. [PDF]

Biomark Res
Wang Z, Gu Y, Sun X, Huang H.
europepmc   +1 more source

Identification of lymphocyte integral membrane proteins as substrates for protein kinase C. Phosphorylation of the interleukin-2 receptor, class I HLA antigens, and T200 glycoprotein.

, 1986
Deborah A. Shackelford, Ian S. Trowbridge   +1 more
openalex   +1 more source

Sensitization of human lymphocytes in vitro: genetic restriction of secondary T cell responses is dictated by the HLA-DR phenotype of antigen-presenting cells. [PDF]

, 1982
Dennis Ford, Anne S. Hamblin, Denis R. Burger   +2 more
openalex   +1 more source